Sunshine Biopharma (SBFMW) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Sunshine Biopharma (SBFMW) over the last 14 years, with Q3 2025 value amounting to -$72.9 million.
- Sunshine Biopharma's Retained Earnings fell 896.01% to -$72.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$72.9 million, marking a year-over-year decrease of 896.01%. This contributed to the annual value of -$69.0 million for FY2024, which is 803.39% down from last year.
- As of Q3 2025, Sunshine Biopharma's Retained Earnings stood at -$72.9 million, which was down 896.01% from -$72.0 million recorded in Q2 2025.
- In the past 5 years, Sunshine Biopharma's Retained Earnings ranged from a high of -$26.4 million in Q1 2021 and a low of -$72.9 million during Q3 2025
- For the 5-year period, Sunshine Biopharma's Retained Earnings averaged around -$53.5 million, with its median value being -$62.0 million (2023).
- Its Retained Earnings has fluctuated over the past 5 years, first tumbled by 8189.95% in 2022, then crashed by 593.45% in 2024.
- Quarter analysis of 5 years shows Sunshine Biopharma's Retained Earnings stood at -$32.7 million in 2021, then crashed by 81.9% to -$59.4 million in 2022, then fell by 7.59% to -$63.9 million in 2023, then dropped by 8.03% to -$69.0 million in 2024, then decreased by 5.55% to -$72.9 million in 2025.
- Its Retained Earnings was -$72.9 million in Q3 2025, compared to -$72.0 million in Q2 2025 and -$70.2 million in Q1 2025.